Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric Subjects with Primary Immunodeficiency Diseases
Clinical Trial Grant
Administered By
Pediatrics, Allergy and Immunology
Awarded By
Baxalta, Inc.
Start Date
January 10, 2019
End Date
January 22, 2020
Administered By
Pediatrics, Allergy and Immunology
Awarded By
Baxalta, Inc.
Start Date
January 10, 2019
End Date
January 22, 2020